Key result
Large observational cohort study evaluates prognostic value of midwall LGE on CMR in ischemic cardiomyopathy.
Why the study?
Does cardiovascular magnetic resonance midwall late gadolinium enhancement predict all-cause mortality in patients with ischaemic cardiomyopathy?
Observational (n=6,082)
Yes
Does cardiovascular magnetic resonance midwall late gadolinium enhancement predict all-cause mortality in patients with ischaemic cardiomyopathy?
No takes yet. Share an insight, caveat, or question.
This study aims to determine if the presence of midwall late gadolinium enhancement on CMR independently predicts all-cause mortality in a large cohort of patients with ischaemic cardiomyopathy.
Unger et al. (2026) conducted an observational in Ischaemic cardiomyopathy (n=6,082). Midwall late gadolinium enhancement (LGE) vs. Absence of midwall LGE was evaluated on All-cause mortality. The abstract outlines the methodology for evaluating the prognostic value of midwall LGE in 6,082 patients with ischemic cardiomyopathy, but no quantitative results or statistical findings are reported.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: